Please login to the form below

Not currently logged in
Email:
Password:

Balversa

This page shows the latest Balversa news and features for those working in and with pharma, biotech and healthcare.

Cancer Research Horizons and Newcastle University extend alliance with Astex

Cancer Research Horizons and Newcastle University extend alliance with Astex

Astex subsequently entered into a drug discovery collaboration and licence agreement on FGFR inhibitors with Janssen – a pharmaceutical arm of Johnson &Johnson – which resulted in the identification of Balversa (erdafitinib), approved

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...